We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Enzo Biochem Inc | NYSE:ENZ | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.04 | 1.08 | 1.025 | 1.04 | 73,102 | 01:00:00 |
From May 2019 to May 2024
By Patrick Thomas
Roche Holdings Ltd. (RHHBY) will pay $21 million patent infringement settlement to Enzo Biochem Inc., Enzo said in a filing with the U.S. Securities and Exchange Commission Monday.
In its 2012 lawsuit, Enzo, a biotechnology company, said that Roche sold certain nucleic acid products in the U.S. used for genetic testing for diseases. The settlement, agreed on by the companies last week, involves several of Roche Holdings' subsidiaries, Roche Diagnostics GmbH and Roche Molecular Systems that make medical equipment.
Enzo said in the filing that this settlement doesn't affect its civil action for patent infringement against Roche in the U.S. District Court for the State of Delaware.
Representatives from Enzo and Roche couldn't be immediately reached for comment.
Write to Patrick Thomas at patrick.thomas@wsj.com
(END) Dow Jones Newswires
February 11, 2019 14:36 ET (19:36 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Enzo Biochem Chart |
1 Month Enzo Biochem Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
